Working together to advance cell manufacturing
CMaT will enable robust, scalable, low-cost biomanufacturing of high-quality therapeutic cells to bring affordable, curative therapies against incurable chronic diseases.
A partnership with the National
Cell Manufacturing Consortium
Undergraduate students from around the United States spent their summer learning about cell manufacturing.
Researchers have demonstrated an integrated technique for monitoring specific biomolecules.
Dr. Carl June, introduced as “the cancer slayer” at an immunotherapy conference here, challenged scientists to be far more aggressive about pushing their perspectives in the White House and Congress.